DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC

Clinical trial NCT06397235 · RECRUITING

Trial details

NCT number: NCT06397235
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2024-05-01
Primary completion: 2027-04-30
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.